.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Medtronic
Merck
Moodys
Mallinckrodt
US Army
Federal Trade Commission
Healthtrust
Fuji

Generated: November 22, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: dalfampridine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Acorda
AMPYRA
dalfampridine
TABLET, EXTENDED RELEASE;ORAL022250NDAAcorda Therapeutics, Inc.10144-427-6060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10144-427-60)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Novartis
Julphar
Cipla
Medtronic
UBS
Accenture
Federal Trade Commission
McKinsey
Fish and Richardson

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot